chr1-61861632-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001350145.3(PATJ):āc.2404G>Cā(p.Asp802His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00211 in 1,471,416 control chromosomes in the GnomAD database, including 65 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.012 ( 39 hom., cov: 30)
Exomes š: 0.0010 ( 26 hom. )
Consequence
PATJ
NM_001350145.3 missense
NM_001350145.3 missense
Scores
2
16
Clinical Significance
Conservation
PhyloP100: 2.06
Genes affected
PATJ (HGNC:28881): (PATJ crumbs cell polarity complex component) This gene encodes a protein with multiple PDZ domains. PDZ domains mediate protein-protein interactions, and proteins with multiple PDZ domains often organize multimeric complexes at the plasma membrane. This protein localizes to tight junctions and to the apical membrane of epithelial cells. A similar protein in Drosophila is a scaffolding protein which tethers several members of a multimeric signaling complex in photoreceptors. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.002489537).
BP6
Variant 1-61861632-G-C is Benign according to our data. Variant chr1-61861632-G-C is described in ClinVar as [Benign]. Clinvar id is 775134.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0115 (1754/152108) while in subpopulation AFR AF= 0.0403 (1670/41484). AF 95% confidence interval is 0.0386. There are 39 homozygotes in gnomad4. There are 821 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 39 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PATJ | NM_001350145.3 | c.2404G>C | p.Asp802His | missense_variant | 19/44 | ENST00000642238.2 | NP_001337074.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PATJ | ENST00000642238.2 | c.2404G>C | p.Asp802His | missense_variant | 19/44 | NM_001350145.3 | ENSP00000494277.1 |
Frequencies
GnomAD3 genomes AF: 0.0115 AC: 1751AN: 151990Hom.: 39 Cov.: 30
GnomAD3 genomes
AF:
AC:
1751
AN:
151990
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00291 AC: 534AN: 183542Hom.: 12 AF XY: 0.00215 AC XY: 219AN XY: 101676
GnomAD3 exomes
AF:
AC:
534
AN:
183542
Hom.:
AF XY:
AC XY:
219
AN XY:
101676
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00103 AC: 1355AN: 1319308Hom.: 26 Cov.: 22 AF XY: 0.000950 AC XY: 625AN XY: 658176
GnomAD4 exome
AF:
AC:
1355
AN:
1319308
Hom.:
Cov.:
22
AF XY:
AC XY:
625
AN XY:
658176
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0115 AC: 1754AN: 152108Hom.: 39 Cov.: 30 AF XY: 0.0110 AC XY: 821AN XY: 74368
GnomAD4 genome
AF:
AC:
1754
AN:
152108
Hom.:
Cov.:
30
AF XY:
AC XY:
821
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
177
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
474
Asia WGS
AF:
AC:
6
AN:
3476
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 31, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T;T;T
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;.;M;.
PrimateAI
Benign
T
PROVEAN
Benign
.;N;N;.
REVEL
Benign
Sift
Benign
.;T;T;.
Sift4G
Benign
.;T;T;T
Polyphen
0.76
.;.;P;.
Vest4
0.25, 0.18
MVP
0.56
MPC
0.48
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at